New hope for sarcoma: drug may stall tumor growth
NCT ID NCT01900743
First seen Apr 12, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This study tested the drug regorafenib in 219 people with soft tissue sarcoma that had spread and was no longer responding to standard chemotherapy. The goal was to see if the drug could slow down the cancer's growth. Participants were randomly assigned to receive either regorafenib or a placebo, and the study measured how long they lived without the cancer getting worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AKH-Wien
Vienna, 1090, Austria
-
Centre Alexis Vautrin
Vandœuvre-lès-Nancy, 54519, France
-
Centre Antoine Lacassagne
Nice, 06189, France
-
Centre Eugène Marquis
Rennes, 35042, France
-
Centre François Baclesse
Caen, 14076, France
-
Centre GF Leclercq
Dijon, 21079, France
-
Centre Henri Becquerel
Rouen, 76038, France
-
Centre Léon Bérard
Lyon, 69373, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Centre René Gauducheau
Nantes, 44805, France
-
Hôpital Cochin
Paris, 75014, France
-
Hôpital Saint Louis
Paris, 75010, France
-
Hôpital St Jacques
Besançon, 25000, France
-
Hôpital de La Timone
Marseille, 13354, France
-
Institut Bergonié
Bordeaux, 33076, France
-
Institut Claudius Regaud
Toulouse, 32052, France
-
Institut Curie
Paris, 75005, France
-
Institut Curie - Hôpital René Huguenin
Saint-Cloud, 92210, France
-
Institut Gustave Roussy
Villejuif, 94800, France
-
Institut Paoli Calmettes
Marseille, 13273, France
-
Institut de Cancérologie Lucien Neuwirth (ICL)
Saint-Priest-en-Jarez, 42270, France
-
Krankenhaus der Barmherzigen Schwestern Linz
Linz, 4010, Austria
-
LKH
Klagenfurt, Austria
-
Medizinische Universität Graz
Graz, 8036, Austria
-
Universitätsklinik für Innere Medizin I
Innsbruck, 6020, Austria
Conditions
Explore the condition pages connected to this study.